Last reviewed · How we verify
Liquid pergoveris
At a glance
| Generic name | Liquid pergoveris |
|---|---|
| Sponsor | Merck KGaA, Darmstadt, Germany |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pergoveris FD and Liquid China BE Study (PHASE1)
- "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"
- Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female Subjects (PHASE1)
- Androgenic Profile Following Controlled Ovarian Stimulation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liquid pergoveris CI brief — competitive landscape report
- Liquid pergoveris updates RSS · CI watch RSS
- Merck KGaA, Darmstadt, Germany portfolio CI